Indeed it was a doozy. That was during the white h
Post# of 72447
(Total Views: 361)
Posted On: 01/07/2018 9:23:43 PM
Indeed it was a doozy. That was during the white hot immunotherapy craze - a perfect storm if you will.
Not sure why he thinks our pipeline trumps theirs. They only had one drug but it was worth over $40B (the $21B mentioned was for half the sales).
I suppose it's possible a fully developed Brilacidin platform could be worth that. Kevetrin also has the potential to be larger. We're a long way from both though.
Let's focus on 1% of that success and get our market cap back to $400M in 2018. From there we can dream of $4B and beyond.
Go IPIX!
Not sure why he thinks our pipeline trumps theirs. They only had one drug but it was worth over $40B (the $21B mentioned was for half the sales).
I suppose it's possible a fully developed Brilacidin platform could be worth that. Kevetrin also has the potential to be larger. We're a long way from both though.
Let's focus on 1% of that success and get our market cap back to $400M in 2018. From there we can dream of $4B and beyond.
Go IPIX!
(1)
(2)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.